TD Cowen Maintains Buy on BioLife Solns, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Steven Mah maintains a Buy rating on BioLife Solutions (NASDAQ:BLFS) and raises the price target from $20 to $26.
July 17, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Steven Mah maintains a Buy rating on BioLife Solutions and raises the price target from $20 to $26.
The Buy rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100